Related Experiment Video
Updated: May 16, 2026

09:01
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Minimally invasive procedures for intracerebral hematoma evacuation in early stages decrease perihematomal glutamate
Guofeng Wu1, Likun Wang, Fan Wang
1Emergency Department, Affiliated Hospital of Guiyang Medical College, No. 28, Guiyijie Road, Liuguangmen, Guiyang City, Guizhou Province 550004, PR China. wuguofeng3013@sina.com
Brain Research
|November 28, 2012
Summary
Performing minimally invasive surgery for intracerebral hemorrhage (ICH) within 6-12 hours is optimal. This timing significantly reduces perihematomal glutamate levels, BBB permeability, and neurological deficits.
Area of Science:
- Neurosurgery
- Neurology
- Biomedical Engineering
Background:
- Intracerebral hemorrhage (ICH) is a critical neurological condition.
- Elevated glutamate levels and blood-brain barrier (BBB) permeability exacerbate brain damage post-ICH.
- Minimally invasive surgery (MIS) is a potential treatment strategy for ICH.
Purpose of the Study:
- To investigate the impact of timing for minimally invasive procedures on glutamate levels and neurological function after ICH.
- To determine the optimal time window for MIS in ICH management.
Main Methods:
- An ICH model was created in 48 rabbits.
- Rabbits were divided into a control group and a minimally invasive group.
- Minimally invasive procedures were performed at 6, 12, 18, or 24 hours post-ICH.
Main Results:
- Minimally invasive surgery significantly reduced neurological deficit scores, perihematomal glutamate levels, and BBB permeability compared to controls.
- The most substantial improvements were observed when MIS was performed within 6 to 12 hours after ICH.
- This timing demonstrated the greatest reduction in glutamate, BBB permeability, and neurological deficits.
Conclusions:
- The optimal time window for minimally invasive hematoma evacuation following ICH is likely within 6 to 12 hours.
- Early intervention via MIS can mitigate secondary brain injury associated with ICH.
